A. Ishida-yamamoto et al., Syringocystadenocarcinoma papilliferum: Case report and immunohistochemical comparison with its benign counterpart, J AM ACAD D, 45(5), 2001, pp. 755-759
Syringocystadenocarcinoma papilliferum (SCACP) is the malignant counterpart
of syringocystadenoma papilliferum (SCAP), although only a few cases have
been reported in the literature and its clinical and histologic characteris
tics are not well known. We report a case of SCACP that started as an enlar
ging nodule over 10 years in the perianal area of a 61-year-old man. Macros
copically, the lesion was a black exophytic tumor, 6 cm in diameter, with a
granular surface. Histologically, it was an in situ adenocarcinoma, showin
g cytologic atypia and pagetoid spread in the surrounding epithelia, althou
gh the clinicopathologic features were distinct from extramammary Paget's d
isease. The tumor lacked the typical double-layered pattern of SCAP but had
some similar histopathologic features to SCAP. Decapitation secretion was
apparent and there was positive immunoreactivity to epithelial membrane ant
igen and human milk fat globules subclass 2. SCACP is a rare cutaneous tumo
r but nevertheless represents a specific dermatopathologic entity.